Literature DB >> 31275070

Current Status of Segmental Colectomy in Select Crohn's Disease Patients.

Alexander Heriot1, Philip Smart2,3.   

Abstract

Crohn's disease is a complex disease with a varying clinical and anatomical spectrum. One-third of patients with Crohn's will have disease confined to the colon. In this article, the authors review the surgical treatment options for colonic Crohn's disease including the current status of performing segmental colectomy in colonic Crohn's, the pros and cons of segmental versus subtotal colectomy, and the influence of biologics on recurrence rates following segmental colectomy.

Entities:  

Keywords:  Crohn's disease; anti-TNF; colitis; inflammatory disorder; surgical treatment

Year:  2019        PMID: 31275070      PMCID: PMC6606324          DOI: 10.1055/s-0039-1683906

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  53 in total

Review 1.  Operations for Crohn's colitis: limited resection and preservation of anorectal function.

Authors:  G Olaison; R Sjödahl
Journal:  Eur J Surg       Date:  1998-12

2.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

Authors:  G D'haens; S Van Deventer; R Van Hogezand; D Chalmers; C Kothe; F Baert; T Braakman; T Schaible; K Geboes; P Rutgeerts
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

3.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 4.  Crohn's disease of the colon.

Authors:  T S Guy; N N Williams; E F Rosato
Journal:  Surg Clin North Am       Date:  2001-02       Impact factor: 2.741

5.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

6.  Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.

Authors:  E Louis; A Collard; A F Oger; E Degroote; F A Aboul Nasr El Yafi; J Belaiche
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

7.  Infliximab decreases resource use among patients with Crohn's disease.

Authors:  Joel H Rubenstein; Rachel Y Chong; Russell D Cohen
Journal:  J Clin Gastroenterol       Date:  2002-08       Impact factor: 3.062

8.  Long-term evolution of disease behavior of Crohn's disease.

Authors:  Jacques Cosnes; Stéphane Cattan; Antoine Blain; Laurent Beaugerie; Franck Carbonnel; Rolland Parc; Jean-Pierre Gendre
Journal:  Inflamm Bowel Dis       Date:  2002-07       Impact factor: 5.325

9.  Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.

Authors:  Jean Frédéric Colombel; Edward V Loftus; William J Tremaine; John H Pemberton; Bruce G Wolff; Tonia Young-Fadok; William S Harmsen; Cathy D Schleck; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

10.  Long-term outcome of endoscopic pneumatic dilatation in Crohn's disease.

Authors:  S Morini; C Hassan; R Lorenzetti; A Zullo; P Cerro; S Winn; M Giustini; F Taggi
Journal:  Dig Liver Dis       Date:  2003-12       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.